What happened
Tempus AI (TEM) sequences tumours for cancer patients and licenses the resulting data to pharmaceutical companies and researchers.
TEMTempus AI·2026Q2 10-QPaidFiling score 76 · Large change
Sponsored links — aiSwingX™ may earn a commission at no extra cost to you. They never affect our articles, scores or rankings.
Tempus AI's first quarterly profit of $5.6m came from below the operating line
Q2 2026 10-Q: revenue $382.5m (+22%) with an operating loss wider than a year earlier, yet net income is positive. That profit comes from listed shares remeasured every quarter
Tempus AI (TEM) reported second-quarter 2026 revenue of $382.5m, up 22%, and swung from a $42.8m net loss a year earlier to **net income of $5.6m**. Reading down the income statement in the 10-Q filed on July 24 shows where that profit came from: the operating result is a loss of $75.9m, and the line beneath it, other income net, is $102.8m.
In plain terms
Tempus AI posted its first quarterly profit, $5.6m. The core testing and data business lost $75.9m; the profit came from $102.8m of items below the operating line, mostly gains on shares the company holds in other listed companies. Share prices move both ways, so this line changes direction each quarter — in the first quarter it was negative, which is why the half-year total is smaller than the second quarter alone.
What the numbers meanSubscribers
Why it mattersSubscribers
Company explanation and contextSubscribers
What to watchSubscribers
Arithmetic table · quarterly metricsSubscribers
End of the free preview
76 Filing score · Large change
What the numbers mean — for subscribers
We find the numbers that are in the filing but not in the news, and analyze what they mean, how big they are and what to watch next quarter — with the arithmetic and quarterly metrics. Cancel any time.
$10.99/mo · $109/yr
Log in to subscribe
Not ready to subscribe? Get free alerts when new articles go out.
Only on days we publish. Unsubscribe any time.
FAQ
Is the profit not real?
The net income figure is what the income statement reports. The remaining figures and what they mean are set out in the subscriber section.
Does other income recur at this level?
The filing's own numbers say no.
How is the operating business doing?
Revenue grew, split between data and applications and genomic testing. The figures for each are in the subscriber section.
Where can I verify these numbers?
On SEC EDGAR: the Q2 2026 Form 10-Q (accession 0001193125-26-326090) — 'Loss from operations', 'Other income, net' and 'Loss on debt extinguishment' in the statement of operations, 'Gain on marketable equity securities' in the cash-flow statement, Note 15 Fair Value Measurements and Marketable Equity Securities, and the liquidity section of MD&A.
How aiSwingX™ wrote this
- We read the filing on SEC EDGAR in full — statements, notes, MD&A. Press releases and news are not used as sources.
- Every figure is reconciled to its location in the filing and to XBRL data. One mismatch means no publication.
- An editor reviews before publication; any later change is recorded in the revision history.
© 2026 aiSwingX™. All rights reserved. Quote with attribution. Republication, redistribution and data use are governed by the Terms of Service and License. Not investment advice.
Tempus AI Form 10-Q for Q2 2026 (as of June 30): statement of operations (operating loss, other income, loss on debt extinguishment, equity-method losses), cash-flow statement (gain on marketable equity securities, stock-based compensation), Note 15 Fair Value Measurements and Marketable Equity Securities, balance sheet (receivables, cash) and the revenue and liquidity sections of MD&A · SEC EDGAR · This article is not investment advice. Disclaimer